Results 181 to 190 of about 3,310,854 (363)

Treatment Survival in Patients With Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Despite the existence of therapeutic approaches, effective management of hidradenitis suppurativa (HS) remains elusive in many cases. In addition, most of the current studies focus on treatment response in a cross‐sectional analysis of patients, and therefore a proper study analysing different treatment strategies longitudinally in ...
Lea Schulte‐Oestrich, Simone Cazzaniga, Robert E. Hunger, S. Morteza Seyed Jafari   +3 more
wiley   +1 more source

Potential Use of Essential Oil Isolated fromCleistocalyx operculatusLeaves as a Topical Dermatological Agent for Treatment of Burn Wound [PDF]

, 2018
Gia‐Buu Tran, Nghia-Thu Tram Le, Dam Sao   +2 more
openalex   +1 more source

Drug utilization pattern evaluation and cost variation analysis of anti-fungal agents in tinea infected patients in dermatology department of a tertiary care teaching hospital

, 2023
Ritu D. Modi, Gurusharan H. Dumra
openalex   +2 more sources

Sun Exposure Behaviors of Patients With Moderate‐to‐Severe Psoriasis: Results From the French PSOBIOTEQ Cohort

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Tanning addiction is a behavioral addiction characterized by an irrepressible desire for sun or ultraviolet light exposure. It is thought to affect 10% to 25% of the population. Objectives This study aimed to estimate the prevalence of this behavior in patients with moderate‐to‐severe psoriasis and identify associated factors ...
E. Mahé, R. Curmin, C. Paul, H. Bachelez, M. Beylot‐Barry, N. Beneton, A. Dupuy, P. Joly, D. Jullien, M.‐A. Richard, M. Viguier, E. Sbidian, O. Chosidow, F. Tubach, the PsoBioTeq Study group   +14 more
wiley   +1 more source

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database. [PDF]

Front Pharmacol
Wu YY, Huang QL, Luo ZY, Song XY, Shi YY, Zheng JZ, Liu S.   +6 more
europepmc   +1 more source

Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib

JEADV Clinical Practice, EarlyView.
ABSTRACT We present the case of a 79‐year‐old female patient diagnosed with psoriasis who developed paradoxical drug reactions after administration of anti‐IL17 and anti‐IL‐23 inhibitors. Having shifted towards a rather eczematous phenotype, the patient received an anti‐IL‐4/IL‐3 inhibitor, subsequently developing erythroderma.
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, Natalija Novak, Joerg Wenzel   +4 more
wiley   +1 more source

Systemic Risks of Topical Anesthetics in Barrier-Compromised Dermatologic Patients. [PDF]

Cureus
Chamoun G, Forsyth A, Kazemeini S, Ma J, Lam K, Kasiri N, Frasier KM.   +6 more
europepmc   +1 more source

Dermatologic toxicity occurring during anti-EGFR monoclonal inhibitor therapy in patients with metastatic colorectal cancer: A systematic review [PDF]

, 2018
Anadkat, Milan, Bohac, Chet, Garawin, Tamer, Jatoi, Aminah, Lacouture, Mario E, Mitchell, Edith   +5 more
core   +1 more source

Effect of diet and atmosphere on intestinal and skin flora. Volume II - Literature survey [PDF]

Literature survey and experimental observations of human skin microflora, including study of men confined in simulated spacecraft ...
Gall, L. S., Riely, P. E.
core   +2 more sources

Finnish Tattooists Express Concerns Over New REACH‐Compliant Tattoo Inks

JEADV Clinical Practice, EarlyView.
Nicolas Kluger, Jenni Kiiski, Laura Koski   +2 more
wiley   +1 more source